

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.43675009 |
| 2 | daunorubicin metabolic process (GO:0044597) | 6.26394313 |
| 3 | polyketide metabolic process (GO:0030638) | 6.26394313 |
| 4 | doxorubicin metabolic process (GO:0044598) | 6.26394313 |
| 5 | regulation of response to osmotic stress (GO:0047484) | 6.22588795 |
| 6 | estrogen biosynthetic process (GO:0006703) | 5.72193626 |
| 7 | somite rostral/caudal axis specification (GO:0032525) | 5.14811877 |
| 8 | protein neddylation (GO:0045116) | 4.96135401 |
| 9 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.94017868 |
| 10 | maintenance of protein location in nucleus (GO:0051457) | 4.82388435 |
| 11 | negative regulation of epidermis development (GO:0045683) | 4.81652185 |
| 12 | thrombin receptor signaling pathway (GO:0070493) | 4.77121748 |
| 13 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.22568818 |
| 14 | hemidesmosome assembly (GO:0031581) | 4.17987048 |
| 15 | positive regulation of macrophage cytokine production (GO:0060907) | 4.05073004 |
| 16 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.97103060 |
| 17 | notochord development (GO:0030903) | 3.93980580 |
| 18 | muscle organ morphogenesis (GO:0048644) | 3.87847045 |
| 19 | negative regulation of protein localization to cell surface (GO:2000009) | 3.79520736 |
| 20 | biotin metabolic process (GO:0006768) | 3.78383547 |
| 21 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.74912041 |
| 22 | bone trabecula formation (GO:0060346) | 3.73005556 |
| 23 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.68290901 |
| 24 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.66382722 |
| 25 | hormone catabolic process (GO:0042447) | 3.65663366 |
| 26 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.63731333 |
| 27 | regulation of lipoprotein metabolic process (GO:0050746) | 3.63365999 |
| 28 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.62740798 |
| 29 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.54685440 |
| 30 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.53439417 |
| 31 | regulation of platelet aggregation (GO:0090330) | 3.49514611 |
| 32 | tachykinin receptor signaling pathway (GO:0007217) | 3.49207792 |
| 33 | melanin biosynthetic process (GO:0042438) | 3.41713804 |
| 34 | heme transport (GO:0015886) | 3.41274513 |
| 35 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.40576891 |
| 36 | negative regulation of platelet activation (GO:0010544) | 3.39048418 |
| 37 | renal absorption (GO:0070293) | 3.38170211 |
| 38 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.37945730 |
| 39 | organic cation transport (GO:0015695) | 3.36638490 |
| 40 | ensheathment of neurons (GO:0007272) | 3.35643926 |
| 41 | axon ensheathment (GO:0008366) | 3.35643926 |
| 42 | asymmetric protein localization (GO:0008105) | 3.33399666 |
| 43 | neurotransmitter catabolic process (GO:0042135) | 3.33157033 |
| 44 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.28099867 |
| 45 | mesodermal cell differentiation (GO:0048333) | 3.27434826 |
| 46 | negative regulation of heart rate (GO:0010459) | 3.27219708 |
| 47 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.27012024 |
| 48 | regulation of gonadotropin secretion (GO:0032276) | 3.26892883 |
| 49 | negative regulation of cell fate commitment (GO:0010454) | 3.26375466 |
| 50 | protein localization to kinetochore (GO:0034501) | 3.25578845 |
| 51 | transepithelial transport (GO:0070633) | 3.24055436 |
| 52 | hypotonic response (GO:0006971) | 3.20968209 |
| 53 | plasma membrane fusion (GO:0045026) | 3.17942018 |
| 54 | Leydig cell differentiation (GO:0033327) | 3.17668420 |
| 55 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.17455663 |
| 56 | regulation of hippo signaling (GO:0035330) | 3.16811072 |
| 57 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.14635931 |
| 58 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.14128019 |
| 59 | myelination (GO:0042552) | 3.13939651 |
| 60 | icosanoid secretion (GO:0032309) | 3.13429453 |
| 61 | arachidonic acid secretion (GO:0050482) | 3.13429453 |
| 62 | sphingoid metabolic process (GO:0046519) | 3.12707488 |
| 63 | response to water (GO:0009415) | 3.12197020 |
| 64 | response to dietary excess (GO:0002021) | 3.11982558 |
| 65 | negative regulation of response to food (GO:0032096) | 3.11769676 |
| 66 | negative regulation of appetite (GO:0032099) | 3.11769676 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 3.09662636 |
| 68 | cytidine metabolic process (GO:0046087) | 3.09211739 |
| 69 | cytidine catabolic process (GO:0006216) | 3.09211739 |
| 70 | cytidine deamination (GO:0009972) | 3.09211739 |
| 71 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.07617563 |
| 72 | coenzyme catabolic process (GO:0009109) | 3.07231759 |
| 73 | microtubule severing (GO:0051013) | 3.06468644 |
| 74 | establishment of endothelial barrier (GO:0061028) | 3.05521318 |
| 75 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.05152161 |
| 76 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.04503613 |
| 77 | positive regulation of digestive system process (GO:0060456) | 3.03699735 |
| 78 | multicellular organism reproduction (GO:0032504) | 2.98537594 |
| 79 | relaxation of smooth muscle (GO:0044557) | 2.98135747 |
| 80 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.97762401 |
| 81 | central nervous system myelination (GO:0022010) | 2.96773170 |
| 82 | axon ensheathment in central nervous system (GO:0032291) | 2.96773170 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96081614 |
| 84 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.94835724 |
| 85 | nucleoside transmembrane transport (GO:1901642) | 2.94471838 |
| 86 | regulation of platelet activation (GO:0010543) | 2.94034687 |
| 87 | regulation of endothelial cell differentiation (GO:0045601) | 2.93938802 |
| 88 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.93544512 |
| 89 | secondary metabolite biosynthetic process (GO:0044550) | 2.93456478 |
| 90 | cofactor transport (GO:0051181) | 2.91989523 |
| 91 | rRNA transcription (GO:0009303) | 2.90942720 |
| 92 | histone H4-K5 acetylation (GO:0043981) | 2.90578540 |
| 93 | histone H4-K8 acetylation (GO:0043982) | 2.90578540 |
| 94 | melanin metabolic process (GO:0006582) | 2.90293761 |
| 95 | creatine metabolic process (GO:0006600) | 2.90148438 |
| 96 | phenol-containing compound catabolic process (GO:0019336) | 2.88468258 |
| 97 | endosome to melanosome transport (GO:0035646) | 2.87899170 |
| 98 | endosome to pigment granule transport (GO:0043485) | 2.87899170 |
| 99 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.87774012 |
| 100 | maintenance of protein localization in organelle (GO:0072595) | 2.87204813 |
| 101 | icosanoid transport (GO:0071715) | 2.87145564 |
| 102 | fatty acid derivative transport (GO:1901571) | 2.87145564 |
| 103 | response to gravity (GO:0009629) | 2.85948351 |
| 104 | epoxygenase P450 pathway (GO:0019373) | 2.85847057 |
| 105 | diol metabolic process (GO:0034311) | 2.85712049 |
| 106 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.85501577 |
| 107 | cardiovascular system development (GO:0072358) | 2.85048985 |
| 108 | negative regulation of telomerase activity (GO:0051974) | 2.85048314 |
| 109 | proline transport (GO:0015824) | 2.81884738 |
| 110 | regulation of cilium movement (GO:0003352) | 2.80205099 |
| 111 | dopamine transport (GO:0015872) | 2.80085209 |
| 112 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.79292624 |
| 113 | maternal placenta development (GO:0001893) | 2.77862027 |
| 114 | regulation of telomerase activity (GO:0051972) | 2.77577012 |
| 115 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.76714000 |
| 116 | cellular response to vitamin D (GO:0071305) | 2.75058978 |
| 117 | regulation of cell fate commitment (GO:0010453) | 2.74202459 |
| 118 | androgen biosynthetic process (GO:0006702) | 2.74052133 |
| 119 | glycerophospholipid catabolic process (GO:0046475) | 2.73324590 |
| 120 | histone H4-K12 acetylation (GO:0043983) | 2.72796946 |
| 121 | lateral sprouting from an epithelium (GO:0060601) | 2.71827402 |
| 122 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.71083887 |
| 123 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.70665258 |
| 124 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.69917450 |
| 125 | anterior/posterior axis specification (GO:0009948) | 2.69527019 |
| 126 | virion attachment to host cell (GO:0019062) | 2.67584733 |
| 127 | adhesion of symbiont to host cell (GO:0044650) | 2.67584733 |
| 128 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.67188202 |
| 129 | glutathione biosynthetic process (GO:0006750) | 2.67012693 |
| 130 | diaphragm development (GO:0060539) | 2.66282803 |
| 131 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.65833017 |
| 132 | adenosine receptor signaling pathway (GO:0001973) | 2.65350386 |
| 133 | estrogen metabolic process (GO:0008210) | 2.65284781 |
| 134 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.64630522 |
| 135 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.64436079 |
| 136 | chromatin assembly (GO:0031497) | 2.64430622 |
| 137 | serotonin metabolic process (GO:0042428) | 2.63857300 |
| 138 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.61522251 |
| 139 | cellular response to osmotic stress (GO:0071470) | 2.60692431 |
| 140 | protein localization to chromosome, centromeric region (GO:0071459) | 2.60688033 |
| 141 | phagocytosis, recognition (GO:0006910) | 2.60531345 |
| 142 | cyclooxygenase pathway (GO:0019371) | 2.59399436 |
| 143 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.57101916 |
| 144 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.56594367 |
| 145 | neuronal action potential propagation (GO:0019227) | 2.54207793 |
| 146 | primary amino compound metabolic process (GO:1901160) | 2.51210982 |
| 147 | male meiosis (GO:0007140) | 2.51061840 |
| 148 | neuronal action potential (GO:0019228) | 2.50929512 |
| 149 | platelet dense granule organization (GO:0060155) | 2.50250968 |
| 150 | positive regulation of receptor recycling (GO:0001921) | 2.50092275 |
| 151 | angiogenesis involved in wound healing (GO:0060055) | 2.48123823 |
| 152 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.47283188 |
| 153 | sperm motility (GO:0030317) | 2.46777855 |
| 154 | piRNA metabolic process (GO:0034587) | 2.46153805 |
| 155 | cellular biogenic amine catabolic process (GO:0042402) | 2.44693470 |
| 156 | amine catabolic process (GO:0009310) | 2.44693470 |
| 157 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.43603457 |
| 158 | fatty acid elongation (GO:0030497) | 2.41626230 |
| 159 | behavioral response to nicotine (GO:0035095) | 2.39859757 |
| 160 | melanosome organization (GO:0032438) | 2.39230419 |
| 161 | autophagic vacuole fusion (GO:0000046) | 2.38697215 |
| 162 | platelet aggregation (GO:0070527) | 2.38319615 |
| 163 | regulation of response to food (GO:0032095) | 2.37061301 |
| 164 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.36601648 |
| 165 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.36561017 |
| 166 | negative regulation of neurotransmitter transport (GO:0051589) | 2.36009349 |
| 167 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.35596320 |
| 168 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.35276410 |
| 169 | cyclic nucleotide catabolic process (GO:0009214) | 2.35141396 |
| 170 | L-fucose catabolic process (GO:0042355) | 2.31645389 |
| 171 | fucose catabolic process (GO:0019317) | 2.31645389 |
| 172 | L-fucose metabolic process (GO:0042354) | 2.31645389 |
| 173 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.30579686 |
| 174 | prostate gland growth (GO:0060736) | 2.30575246 |
| 175 | righting reflex (GO:0060013) | 2.29875626 |
| 176 | phosphorelay signal transduction system (GO:0000160) | 2.29590937 |
| 177 | regulation of neurotransmitter uptake (GO:0051580) | 2.29417259 |
| 178 | regulation of sensory perception (GO:0051931) | 2.29196302 |
| 179 | regulation of sensory perception of pain (GO:0051930) | 2.29196302 |
| 180 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.29001178 |
| 181 | detection of light stimulus involved in visual perception (GO:0050908) | 2.29001178 |
| 182 | phenol-containing compound biosynthetic process (GO:0046189) | 2.28778462 |
| 183 | microtubule polymerization or depolymerization (GO:0031109) | 2.28330871 |
| 184 | protein K11-linked deubiquitination (GO:0035871) | 2.28318738 |
| 185 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.28147716 |
| 186 | protein polyglutamylation (GO:0018095) | 2.27482326 |
| 187 | sphingosine metabolic process (GO:0006670) | 2.26352725 |
| 188 | microtubule depolymerization (GO:0007019) | 2.25350610 |
| 189 | purinergic receptor signaling pathway (GO:0035587) | 2.24391048 |
| 190 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.23165705 |
| 191 | adenosine metabolic process (GO:0046085) | 2.22995935 |
| 192 | myelin assembly (GO:0032288) | 2.22464241 |
| 193 | acrosome reaction (GO:0007340) | 2.22116344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.97195915 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.97195915 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.97195915 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.76519689 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.52226974 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75270632 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.94890239 |
| 8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.56720270 |
| 9 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.53341204 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.44989983 |
| 11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.40428581 |
| 12 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.37578438 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.33489961 |
| 14 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.31285646 |
| 15 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.30489689 |
| 16 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.25940334 |
| 17 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.22738722 |
| 18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.19187250 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.17577124 |
| 20 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.16095932 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.15862824 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.15161478 |
| 23 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.14369540 |
| 24 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.09508052 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.09354984 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.02699825 |
| 27 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.01581491 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.99359415 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.96030461 |
| 30 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.94918740 |
| 31 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.93967409 |
| 32 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.91644830 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89642470 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.89042500 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.85332394 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83776997 |
| 37 | TP53_16413492_ChIP-PET_HCT116_Human | 1.80942130 |
| 38 | STAT3_23295773_ChIP-Seq_U87_Human | 1.79847011 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78673701 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.73291095 |
| 41 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.72376219 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.68415402 |
| 43 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68086710 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67844664 |
| 45 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.66823819 |
| 46 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.66132312 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65418890 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64869554 |
| 49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.64493779 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.63223016 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.60795061 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60646966 |
| 53 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.60638617 |
| 54 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.60228836 |
| 55 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.59580861 |
| 56 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.57899047 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56185483 |
| 58 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.55516497 |
| 59 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.54578701 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52129362 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50765422 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.49583445 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48995301 |
| 64 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.48937604 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.48856742 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.48856742 |
| 67 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.48374184 |
| 68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.47304754 |
| 69 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46753020 |
| 70 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.46031175 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46004225 |
| 72 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43759544 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.42721619 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42509338 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38923050 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.38479223 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38427599 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38122200 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37224521 |
| 80 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35869017 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35330561 |
| 82 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33732107 |
| 83 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33252241 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33126637 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32316650 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32133802 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31883227 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30711338 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29234626 |
| 90 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28478218 |
| 91 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28293721 |
| 92 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.27689788 |
| 93 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.26874821 |
| 94 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26405441 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25997895 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25997895 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25706352 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.25630189 |
| 99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25481662 |
| 100 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25099481 |
| 101 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.24688554 |
| 102 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.24468632 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24069062 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.21809847 |
| 105 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20837908 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20566670 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20556910 |
| 108 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.20337734 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18700403 |
| 110 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18403506 |
| 111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17145644 |
| 112 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16996536 |
| 113 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.16979246 |
| 114 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16769154 |
| 115 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16304308 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15138081 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14643756 |
| 118 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13898012 |
| 119 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13692014 |
| 120 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13682525 |
| 121 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13682525 |
| 122 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13621375 |
| 123 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.13539794 |
| 124 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13165158 |
| 125 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13165158 |
| 126 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12948017 |
| 127 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12853022 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12152679 |
| 129 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.11912069 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11615918 |
| 131 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10815466 |
| 132 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10141449 |
| 133 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09854419 |
| 134 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.09081426 |
| 135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08977095 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08558413 |
| 137 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.08297304 |
| 138 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08182521 |
| 139 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07767875 |
| 140 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.07696405 |
| 141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07362731 |
| 142 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07025188 |
| 143 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06752627 |
| 144 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06294518 |
| 145 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06141879 |
| 146 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05752722 |
| 147 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05559326 |
| 148 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05221373 |
| 149 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05209893 |
| 150 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05198664 |
| 151 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05091880 |
| 152 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04380615 |
| 153 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04193679 |
| 154 | TBL1_22424771_ChIP-Seq_293T_Human | 1.03200121 |
| 155 | JUN_21703547_ChIP-Seq_K562_Human | 1.03153342 |
| 156 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.03023022 |
| 157 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02931765 |
| 158 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.02765216 |
| 159 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.02114675 |
| 160 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01775081 |
| 161 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01726309 |
| 162 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01580632 |
| 163 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01064104 |
| 164 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01028138 |
| 165 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00152861 |
| 166 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99957269 |
| 167 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99407610 |
| 168 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.99186935 |
| 169 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99068137 |
| 170 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97822968 |
| 171 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97004158 |
| 172 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96679931 |
| 173 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96102705 |
| 174 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.95031188 |
| 175 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94975111 |
| 176 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94089724 |
| 177 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92513495 |
| 178 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92470455 |
| 179 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.91538167 |
| 180 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91307619 |
| 181 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.89809006 |
| 182 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88063049 |
| 183 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87767195 |
| 184 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84440108 |
| 185 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84440108 |
| 186 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.84380220 |
| 187 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84301669 |
| 188 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.82897881 |
| 189 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82790979 |
| 190 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.81426148 |
| 191 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80844951 |
| 192 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.80758429 |
| 193 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80481399 |
| 194 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79918520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 9.10538656 |
| 2 | MP0005464_abnormal_platelet_physiology | 4.12054989 |
| 3 | MP0001348_abnormal_lacrimal_gland | 3.77802035 |
| 4 | MP0004272_abnormal_basement_membrane | 3.71018589 |
| 5 | MP0009697_abnormal_copulation | 3.31447769 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.03698146 |
| 7 | MP0001346_abnormal_lacrimal_gland | 2.98336231 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 2.87426047 |
| 9 | MP0003011_delayed_dark_adaptation | 2.59838561 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.56481272 |
| 11 | MP0000015_abnormal_ear_pigmentation | 2.53629418 |
| 12 | MP0000383_abnormal_hair_follicle | 2.40273075 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.35424710 |
| 14 | MP0004381_abnormal_hair_follicle | 2.26613103 |
| 15 | MP0004858_abnormal_nervous_system | 2.25614087 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.22003262 |
| 17 | MP0004043_abnormal_pH_regulation | 2.16105188 |
| 18 | MP0010678_abnormal_skin_adnexa | 2.12473241 |
| 19 | MP0008775_abnormal_heart_ventricle | 2.10226142 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.07986205 |
| 21 | MP0005174_abnormal_tail_pigmentation | 2.06417570 |
| 22 | MP0004147_increased_porphyrin_level | 2.03350229 |
| 23 | MP0005623_abnormal_meninges_morphology | 1.99746507 |
| 24 | MP0009046_muscle_twitch | 1.98714744 |
| 25 | MP0004510_myositis | 1.97502422 |
| 26 | MP0008872_abnormal_physiological_respon | 1.93325693 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 1.91097089 |
| 28 | MP0002736_abnormal_nociception_after | 1.90737001 |
| 29 | MP0008004_abnormal_stomach_pH | 1.84806240 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.84260955 |
| 31 | MP0006082_CNS_inflammation | 1.84134399 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.81836148 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.77901669 |
| 34 | MP0005083_abnormal_biliary_tract | 1.77588933 |
| 35 | MP0008057_abnormal_DNA_replication | 1.76108998 |
| 36 | MP0002095_abnormal_skin_pigmentation | 1.75328483 |
| 37 | MP0000762_abnormal_tongue_morphology | 1.75277324 |
| 38 | MP0000427_abnormal_hair_cycle | 1.73928606 |
| 39 | MP0006054_spinal_hemorrhage | 1.70338534 |
| 40 | MP0000230_abnormal_systemic_arterial | 1.70138253 |
| 41 | MP0001849_ear_inflammation | 1.64637720 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.64594997 |
| 43 | MP0005377_hearing/vestibular/ear_phenot | 1.61116548 |
| 44 | MP0003878_abnormal_ear_physiology | 1.61116548 |
| 45 | MP0004036_abnormal_muscle_relaxation | 1.61090979 |
| 46 | MP0002102_abnormal_ear_morphology | 1.58946274 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.55125570 |
| 48 | MP0002733_abnormal_thermal_nociception | 1.54963454 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.54855170 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.53806225 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.52907525 |
| 52 | MP0001486_abnormal_startle_reflex | 1.50196806 |
| 53 | MP0003315_abnormal_perineum_morphology | 1.49015557 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.46931592 |
| 55 | MP0003045_fibrosis | 1.46406711 |
| 56 | MP0002796_impaired_skin_barrier | 1.46084201 |
| 57 | MP0004484_altered_response_of | 1.44657171 |
| 58 | MP0005310_abnormal_salivary_gland | 1.41324365 |
| 59 | * MP0002272_abnormal_nervous_system | 1.39449554 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.38937096 |
| 61 | MP0005499_abnormal_olfactory_system | 1.38840785 |
| 62 | MP0005394_taste/olfaction_phenotype | 1.38840785 |
| 63 | MP0000685_abnormal_immune_system | 1.38505416 |
| 64 | MP0000579_abnormal_nail_morphology | 1.38146437 |
| 65 | MP0004142_abnormal_muscle_tone | 1.37364170 |
| 66 | MP0003890_abnormal_embryonic-extraembry | 1.37131845 |
| 67 | MP0002098_abnormal_vibrissa_morphology | 1.35611358 |
| 68 | MP0005647_abnormal_sex_gland | 1.34552157 |
| 69 | MP0001970_abnormal_pain_threshold | 1.30867873 |
| 70 | MP0003195_calcinosis | 1.28456869 |
| 71 | MP0003136_yellow_coat_color | 1.28431274 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.26774933 |
| 73 | MP0001905_abnormal_dopamine_level | 1.26068143 |
| 74 | MP0009745_abnormal_behavioral_response | 1.25779755 |
| 75 | MP0003646_muscle_fatigue | 1.25541801 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 1.25380189 |
| 77 | MP0004085_abnormal_heartbeat | 1.22118821 |
| 78 | MP0002735_abnormal_chemical_nociception | 1.21514714 |
| 79 | MP0003950_abnormal_plasma_membrane | 1.18387924 |
| 80 | MP0010386_abnormal_urinary_bladder | 1.16153789 |
| 81 | MP0003122_maternal_imprinting | 1.15883318 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 1.15783358 |
| 83 | MP0000377_abnormal_hair_follicle | 1.15614883 |
| 84 | MP0002064_seizures | 1.13443091 |
| 85 | MP0003638_abnormal_response/metabolism_ | 1.08851529 |
| 86 | MP0000749_muscle_degeneration | 1.06443964 |
| 87 | * MP0000920_abnormal_myelination | 1.05083231 |
| 88 | MP0005023_abnormal_wound_healing | 1.04566696 |
| 89 | MP0002653_abnormal_ependyma_morphology | 1.03310790 |
| 90 | MP0003718_maternal_effect | 1.02348404 |
| 91 | MP0002092_abnormal_eye_morphology | 1.02007708 |
| 92 | MP0005253_abnormal_eye_physiology | 1.01992629 |
| 93 | MP0005165_increased_susceptibility_to | 1.01004133 |
| 94 | MP0003566_abnormal_cell_adhesion | 1.00454080 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.99091739 |
| 96 | MP0001664_abnormal_digestion | 0.97909917 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.97783591 |
| 98 | MP0006138_congestive_heart_failure | 0.97145087 |
| 99 | MP0010030_abnormal_orbit_morphology | 0.96621457 |
| 100 | MP0000647_abnormal_sebaceous_gland | 0.95040517 |
| 101 | MP0002572_abnormal_emotion/affect_behav | 0.92111211 |
| 102 | MP0009643_abnormal_urine_homeostasis | 0.91619813 |
| 103 | * MP0002067_abnormal_sensory_capabilities | 0.91154763 |
| 104 | MP0002972_abnormal_cardiac_muscle | 0.90780201 |
| 105 | MP0004957_abnormal_blastocyst_morpholog | 0.90746352 |
| 106 | MP0000371_diluted_coat_color | 0.90658594 |
| 107 | MP0005670_abnormal_white_adipose | 0.90643297 |
| 108 | MP0005645_abnormal_hypothalamus_physiol | 0.89522510 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.89340502 |
| 110 | MP0002233_abnormal_nose_morphology | 0.88937131 |
| 111 | MP0003879_abnormal_hair_cell | 0.88819389 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.87918509 |
| 113 | MP0005409_darkened_coat_color | 0.87735312 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.86602316 |
| 115 | MP0002932_abnormal_joint_morphology | 0.86202631 |
| 116 | MP0004084_abnormal_cardiac_muscle | 0.85702150 |
| 117 | MP0002075_abnormal_coat/hair_pigmentati | 0.85624959 |
| 118 | * MP0002229_neurodegeneration | 0.85030841 |
| 119 | MP0010329_abnormal_lipoprotein_level | 0.85006340 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.84683591 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.83139051 |
| 122 | MP0010368_abnormal_lymphatic_system | 0.82042371 |
| 123 | MP0005620_abnormal_muscle_contractility | 0.81188576 |
| 124 | MP0005501_abnormal_skin_physiology | 0.80997516 |
| 125 | MP0001293_anophthalmia | 0.80395168 |
| 126 | MP0003938_abnormal_ear_development | 0.79854912 |
| 127 | MP0002108_abnormal_muscle_morphology | 0.79128676 |
| 128 | MP0005171_absent_coat_pigmentation | 0.79065167 |
| 129 | MP0003828_pulmonary_edema | 0.78297536 |
| 130 | MP0001756_abnormal_urination | 0.77542344 |
| 131 | MP0000678_abnormal_parathyroid_gland | 0.76870072 |
| 132 | MP0004924_abnormal_behavior | 0.76738469 |
| 133 | MP0005386_behavior/neurological_phenoty | 0.76738469 |
| 134 | MP0004885_abnormal_endolymph | 0.76302640 |
| 135 | MP0005330_cardiomyopathy | 0.76267381 |
| 136 | MP0000750_abnormal_muscle_regeneration | 0.75657746 |
| 137 | MP0002938_white_spotting | 0.75395304 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 0.74300088 |
| 139 | MP0003300_gastrointestinal_ulcer | 0.73137773 |
| 140 | MP0005187_abnormal_penis_morphology | 0.73043664 |
| 141 | MP0000613_abnormal_salivary_gland | 0.72633783 |
| 142 | MP0003635_abnormal_synaptic_transmissio | 0.72282388 |
| 143 | MP0003137_abnormal_impulse_conducting | 0.72008520 |
| 144 | MP0005084_abnormal_gallbladder_morpholo | 0.71909226 |
| 145 | MP0005275_abnormal_skin_tensile | 0.71718725 |
| 146 | MP0003633_abnormal_nervous_system | 0.71521734 |
| 147 | MP0001672_abnormal_embryogenesis/_devel | 0.71435865 |
| 148 | MP0005380_embryogenesis_phenotype | 0.71435865 |
| 149 | MP0003755_abnormal_palate_morphology | 0.71123610 |
| 150 | MP0000733_abnormal_muscle_development | 0.70856897 |
| 151 | MP0002088_abnormal_embryonic_growth/wei | 0.70815491 |
| 152 | MP0010234_abnormal_vibrissa_follicle | 0.70413616 |
| 153 | MP0002269_muscular_atrophy | 0.69560049 |
| 154 | MP0002063_abnormal_learning/memory/cond | 0.69198090 |
| 155 | MP0000432_abnormal_head_morphology | 0.68505420 |
| 156 | MP0002138_abnormal_hepatobiliary_system | 0.68488925 |
| 157 | MP0003984_embryonic_growth_retardation | 0.68280635 |
| 158 | MP0005408_hypopigmentation | 0.66615923 |
| 159 | MP0001851_eye_inflammation | 0.66270981 |
| 160 | MP0003698_abnormal_male_reproductive | 0.66118845 |
| 161 | MP0001873_stomach_inflammation | 0.66026611 |
| 162 | MP0010771_integument_phenotype | 0.65800622 |
| 163 | MP0001216_abnormal_epidermal_layer | 0.65708512 |
| 164 | MP0001958_emphysema | 0.65413936 |
| 165 | MP0005332_abnormal_amino_acid | 0.65029891 |
| 166 | MP0000566_synostosis | 0.65008506 |
| 167 | MP0008438_abnormal_cutaneous_collagen | 0.64535803 |
| 168 | MP0005410_abnormal_fertilization | 0.64243955 |
| 169 | MP0000467_abnormal_esophagus_morphology | 0.64160258 |
| 170 | MP0000049_abnormal_middle_ear | 0.63854264 |
| 171 | MP0008961_abnormal_basal_metabolism | 0.63723234 |
| 172 | MP0002925_abnormal_cardiovascular_devel | 0.63209100 |
| 173 | MP0004130_abnormal_muscle_cell | 0.63077638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.41787548 |
| 2 | Prolonged bleeding time (HP:0003010) | 5.84508482 |
| 3 | Menorrhagia (HP:0000132) | 5.82639952 |
| 4 | Increased mean platelet volume (HP:0011877) | 5.45131971 |
| 5 | Petechiae (HP:0000967) | 5.34347460 |
| 6 | Abnormal platelet volume (HP:0011876) | 4.73734623 |
| 7 | Hypochromic microcytic anemia (HP:0004840) | 4.50976471 |
| 8 | Hepatoblastoma (HP:0002884) | 3.99827455 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 3.98879601 |
| 10 | Congenital sensorineural hearing impairment (HP:0008527) | 3.93724285 |
| 11 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 3.57677921 |
| 12 | Multiple enchondromatosis (HP:0005701) | 3.53405807 |
| 13 | Purpura (HP:0000979) | 3.52424310 |
| 14 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.52388209 |
| 15 | Epistaxis (HP:0000421) | 3.46814948 |
| 16 | Blue irides (HP:0000635) | 3.44908431 |
| 17 | Decreased central vision (HP:0007663) | 3.34760444 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.26715037 |
| 19 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.22907541 |
| 20 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.22907541 |
| 21 | Gingival bleeding (HP:0000225) | 3.21620310 |
| 22 | Fused cervical vertebrae (HP:0002949) | 3.17107737 |
| 23 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.15713954 |
| 24 | Ulnar claw (HP:0001178) | 3.15031641 |
| 25 | Abnormality of the fovea (HP:0000493) | 3.06965171 |
| 26 | Impaired platelet aggregation (HP:0003540) | 3.02067429 |
| 27 | Abnormal platelet function (HP:0011869) | 3.02067429 |
| 28 | Sensory axonal neuropathy (HP:0003390) | 3.00891124 |
| 29 | Trismus (HP:0000211) | 2.99135449 |
| 30 | Impaired proprioception (HP:0010831) | 2.96676326 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 2.92644278 |
| 32 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.90949977 |
| 33 | Hyperventilation (HP:0002883) | 2.89641141 |
| 34 | Generalized hypopigmentation of hair (HP:0011358) | 2.87818529 |
| 35 | Abnormality of the renal cortex (HP:0011035) | 2.86408688 |
| 36 | Difficulty running (HP:0009046) | 2.86039522 |
| 37 | Congenital, generalized hypertrichosis (HP:0004540) | 2.85152292 |
| 38 | Hypomagnesemia (HP:0002917) | 2.84961051 |
| 39 | Type I diabetes mellitus (HP:0100651) | 2.84849158 |
| 40 | Fair hair (HP:0002286) | 2.84403930 |
| 41 | Gaze-evoked nystagmus (HP:0000640) | 2.84313116 |
| 42 | Partial duplication of thumb phalanx (HP:0009944) | 2.82197699 |
| 43 | Abnormality of the salivary glands (HP:0010286) | 2.79104074 |
| 44 | Hypoplasia of the uterus (HP:0000013) | 2.78800981 |
| 45 | Clumsiness (HP:0002312) | 2.75883003 |
| 46 | Asplenia (HP:0001746) | 2.69719188 |
| 47 | Testicular atrophy (HP:0000029) | 2.69316199 |
| 48 | Rib fusion (HP:0000902) | 2.64736013 |
| 49 | Renal cortical cysts (HP:0000803) | 2.64330684 |
| 50 | Abnormality of binocular vision (HP:0011514) | 2.61661231 |
| 51 | Diplopia (HP:0000651) | 2.61661231 |
| 52 | * Abnormal auditory evoked potentials (HP:0006958) | 2.60671321 |
| 53 | Preauricular pit (HP:0004467) | 2.58987312 |
| 54 | Periauricular skin pits (HP:0100277) | 2.58987312 |
| 55 | Nasolacrimal duct obstruction (HP:0000579) | 2.58649113 |
| 56 | Increased circulating renin level (HP:0000848) | 2.56519235 |
| 57 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.54771630 |
| 58 | Hypoplasia of the fovea (HP:0007750) | 2.54771630 |
| 59 | Gout (HP:0001997) | 2.54040632 |
| 60 | Hypokalemic alkalosis (HP:0001949) | 2.53174259 |
| 61 | Increased connective tissue (HP:0009025) | 2.52657025 |
| 62 | Bundle branch block (HP:0011710) | 2.51720755 |
| 63 | Termporal pattern (HP:0011008) | 2.50585600 |
| 64 | Insidious onset (HP:0003587) | 2.50585600 |
| 65 | Type II lissencephaly (HP:0007260) | 2.48475825 |
| 66 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.47999202 |
| 67 | Renal salt wasting (HP:0000127) | 2.47107734 |
| 68 | Poikilocytosis (HP:0004447) | 2.46821207 |
| 69 | Abnormality of alanine metabolism (HP:0010916) | 2.45357440 |
| 70 | Hyperalaninemia (HP:0003348) | 2.45357440 |
| 71 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.45357440 |
| 72 | Partial duplication of the phalanx of hand (HP:0009999) | 2.42621455 |
| 73 | Cholelithiasis (HP:0001081) | 2.42442367 |
| 74 | Pancreatic cysts (HP:0001737) | 2.39071569 |
| 75 | Attenuation of retinal blood vessels (HP:0007843) | 2.36545140 |
| 76 | Hypopigmentation of the fundus (HP:0007894) | 2.36515406 |
| 77 | Diaphragmatic weakness (HP:0009113) | 2.33867625 |
| 78 | Dyschromatopsia (HP:0007641) | 2.31073216 |
| 79 | Paralysis (HP:0003470) | 2.30650054 |
| 80 | Ventricular tachycardia (HP:0004756) | 2.28183542 |
| 81 | Neoplasm of striated muscle (HP:0009728) | 2.27898294 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 2.27330333 |
| 83 | Upper limb amyotrophy (HP:0009129) | 2.27330333 |
| 84 | Albinism (HP:0001022) | 2.27127869 |
| 85 | Hypoplasia of the iris (HP:0007676) | 2.24991550 |
| 86 | Febrile seizures (HP:0002373) | 2.24380376 |
| 87 | Hemiparesis (HP:0001269) | 2.22519626 |
| 88 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.22388742 |
| 89 | * Onion bulb formation (HP:0003383) | 2.21622858 |
| 90 | Abnormal lung lobation (HP:0002101) | 2.20203981 |
| 91 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.19807709 |
| 92 | Transposition of the great arteries (HP:0001669) | 2.19807709 |
| 93 | Abnormal connection of the cardiac segments (HP:0011545) | 2.19807709 |
| 94 | Cerebellar dysplasia (HP:0007033) | 2.19314399 |
| 95 | Skin pits (HP:0100276) | 2.19096387 |
| 96 | Ocular albinism (HP:0001107) | 2.18749081 |
| 97 | Sex reversal (HP:0012245) | 2.18325518 |
| 98 | Abnormal sex determination (HP:0012244) | 2.18325518 |
| 99 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.17296799 |
| 100 | Hyperactive renin-angiotensin system (HP:0000841) | 2.17132788 |
| 101 | Abnormal gallbladder morphology (HP:0012437) | 2.16563621 |
| 102 | Ependymoma (HP:0002888) | 2.16058262 |
| 103 | Steppage gait (HP:0003376) | 2.15785480 |
| 104 | Pancreatic fibrosis (HP:0100732) | 2.15008678 |
| 105 | Increased CSF protein (HP:0002922) | 2.13433740 |
| 106 | Inability to walk (HP:0002540) | 2.12643468 |
| 107 | Vascular calcification (HP:0004934) | 2.12377113 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 2.11700846 |
| 109 | Shawl scrotum (HP:0000049) | 2.11655797 |
| 110 | Abnormality of the corticospinal tract (HP:0002492) | 2.11023844 |
| 111 | Hand muscle atrophy (HP:0009130) | 2.10671465 |
| 112 | Bruising susceptibility (HP:0000978) | 2.10562581 |
| 113 | Short humerus (HP:0005792) | 2.09182671 |
| 114 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.08865917 |
| 115 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.08258177 |
| 116 | Rhabdomyosarcoma (HP:0002859) | 2.07541062 |
| 117 | Abnormal drinking behavior (HP:0030082) | 2.05604141 |
| 118 | Polydipsia (HP:0001959) | 2.05604141 |
| 119 | Acanthocytosis (HP:0001927) | 2.05074721 |
| 120 | Molar tooth sign on MRI (HP:0002419) | 2.05036687 |
| 121 | Abnormality of midbrain morphology (HP:0002418) | 2.05036687 |
| 122 | Abnormality of the lacrimal duct (HP:0011481) | 2.03266372 |
| 123 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.02092003 |
| 124 | Villous atrophy (HP:0011473) | 2.02092003 |
| 125 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.02051923 |
| 126 | Metabolic alkalosis (HP:0200114) | 2.01662139 |
| 127 | Generalized hypopigmentation (HP:0007513) | 2.00707011 |
| 128 | Cardiovascular calcification (HP:0011915) | 2.00076463 |
| 129 | Abnormality of magnesium homeostasis (HP:0004921) | 1.99940299 |
| 130 | Absent speech (HP:0001344) | 1.98105575 |
| 131 | Progressive cerebellar ataxia (HP:0002073) | 1.96753018 |
| 132 | Abnormality of lateral ventricle (HP:0030047) | 1.94526655 |
| 133 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.92808609 |
| 134 | Abnormality of the musculature of the hand (HP:0001421) | 1.92580076 |
| 135 | Hyperaldosteronism (HP:0000859) | 1.92473940 |
| 136 | Malnutrition (HP:0004395) | 1.92280802 |
| 137 | Anomalous pulmonary venous return (HP:0010772) | 1.91973344 |
| 138 | Adrenal hypoplasia (HP:0000835) | 1.91785968 |
| 139 | Reticulocytosis (HP:0001923) | 1.91549611 |
| 140 | Right ventricular cardiomyopathy (HP:0011663) | 1.91336617 |
| 141 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.88932300 |
| 142 | Delayed epiphyseal ossification (HP:0002663) | 1.88554289 |
| 143 | Iris hypopigmentation (HP:0007730) | 1.87934687 |
| 144 | Onycholysis (HP:0001806) | 1.87762436 |
| 145 | Protruding tongue (HP:0010808) | 1.87751242 |
| 146 | Embryonal renal neoplasm (HP:0011794) | 1.87034006 |
| 147 | Abnormality of the renal medulla (HP:0100957) | 1.86798501 |
| 148 | Rectovaginal fistula (HP:0000143) | 1.86319789 |
| 149 | Rectal fistula (HP:0100590) | 1.86319789 |
| 150 | Premature rupture of membranes (HP:0001788) | 1.85873444 |
| 151 | Hydroxyprolinuria (HP:0003080) | 1.85238981 |
| 152 | Abnormality of proline metabolism (HP:0010907) | 1.85238981 |
| 153 | Abnormality of the pulmonary veins (HP:0011718) | 1.85227427 |
| 154 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.85171840 |
| 155 | Milia (HP:0001056) | 1.84920547 |
| 156 | White forelock (HP:0002211) | 1.84336923 |
| 157 | Broad-based gait (HP:0002136) | 1.84052928 |
| 158 | Chorioretinal atrophy (HP:0000533) | 1.82667346 |
| 159 | Tubular atrophy (HP:0000092) | 1.81903820 |
| 160 | Choroideremia (HP:0001139) | 1.81473521 |
| 161 | Abolished electroretinogram (ERG) (HP:0000550) | 1.81447824 |
| 162 | Syncope (HP:0001279) | 1.81310011 |
| 163 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.81166831 |
| 164 | True hermaphroditism (HP:0010459) | 1.81094270 |
| 165 | Amelogenesis imperfecta (HP:0000705) | 1.80774040 |
| 166 | Polyuria (HP:0000103) | 1.80741612 |
| 167 | Abnormality of chloride homeostasis (HP:0011422) | 1.80537121 |
| 168 | Widely spaced teeth (HP:0000687) | 1.79252487 |
| 169 | Hypoplasia of dental enamel (HP:0006297) | 1.78923365 |
| 170 | Increased purine levels (HP:0004368) | 1.77888395 |
| 171 | Hyperuricemia (HP:0002149) | 1.77888395 |
| 172 | Hyperglycinuria (HP:0003108) | 1.77665851 |
| 173 | Ileus (HP:0002595) | 1.77230073 |
| 174 | Nephronophthisis (HP:0000090) | 1.76520288 |
| 175 | Confusion (HP:0001289) | 1.76181719 |
| 176 | Peripheral hypomyelination (HP:0007182) | 1.75918829 |
| 177 | Atrial fibrillation (HP:0005110) | 1.75721660 |
| 178 | Intellectual disability, profound (HP:0002187) | 1.74853936 |
| 179 | Patchy hypopigmentation of hair (HP:0011365) | 1.73511876 |
| 180 | Atrophic scars (HP:0001075) | 1.73322658 |
| 181 | Poor eye contact (HP:0000817) | 1.72894290 |
| 182 | Increased density of long bones (HP:0006392) | 1.71412165 |
| 183 | Fragile nails (HP:0001808) | 1.71013405 |
| 184 | Genetic anticipation (HP:0003743) | 1.70580255 |
| 185 | Hyporeflexia of lower limbs (HP:0002600) | 1.68052181 |
| 186 | Increased corneal curvature (HP:0100692) | 1.66808376 |
| 187 | Keratoconus (HP:0000563) | 1.66808376 |
| 188 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.66730510 |
| 189 | Disproportionate short-trunk short stature (HP:0003521) | 1.66622737 |
| 190 | Focal motor seizures (HP:0011153) | 1.65860589 |
| 191 | Severe visual impairment (HP:0001141) | 1.65027970 |
| 192 | Medial flaring of the eyebrow (HP:0010747) | 1.64379205 |
| 193 | Abnormality of the ischium (HP:0003174) | 1.64357918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.86699018 |
| 2 | FRK | 4.51088723 |
| 3 | GRK5 | 4.38721052 |
| 4 | LMTK2 | 3.41618151 |
| 5 | ERN1 | 3.18520732 |
| 6 | GRK1 | 3.05095783 |
| 7 | BMPR1B | 2.96510780 |
| 8 | TYRO3 | 2.79520328 |
| 9 | GRK6 | 2.68593261 |
| 10 | WNK4 | 2.61891023 |
| 11 | TGFBR2 | 2.59874907 |
| 12 | STK39 | 2.52481181 |
| 13 | EPHB1 | 2.50278249 |
| 14 | STK10 | 2.48397147 |
| 15 | DAPK2 | 2.27810214 |
| 16 | EPHA2 | 2.25066553 |
| 17 | WNK1 | 2.24000786 |
| 18 | MYLK | 2.18220413 |
| 19 | ACVR1B | 1.97049772 |
| 20 | MET | 1.96718293 |
| 21 | NTRK1 | 1.94325788 |
| 22 | ADRBK2 | 1.92163199 |
| 23 | INSRR | 1.90761893 |
| 24 | PLK2 | 1.89189229 |
| 25 | MATK | 1.88570141 |
| 26 | OXSR1 | 1.87933052 |
| 27 | EIF2AK1 | 1.82962707 |
| 28 | GRK7 | 1.70115127 |
| 29 | MAPK7 | 1.69934325 |
| 30 | TTK | 1.59604301 |
| 31 | TRIM28 | 1.58630658 |
| 32 | WNK3 | 1.53846057 |
| 33 | NUAK1 | 1.53804287 |
| 34 | TIE1 | 1.53178021 |
| 35 | DYRK1B | 1.49508029 |
| 36 | PAK4 | 1.48190969 |
| 37 | MAP4K2 | 1.47970228 |
| 38 | CSF1R | 1.45968670 |
| 39 | MST1R | 1.45863794 |
| 40 | PHKG2 | 1.41733235 |
| 41 | PHKG1 | 1.41733235 |
| 42 | MOS | 1.41027296 |
| 43 | PRKG2 | 1.33830591 |
| 44 | ZAK | 1.31742130 |
| 45 | MAP3K12 | 1.27450442 |
| 46 | DYRK3 | 1.22757186 |
| 47 | TEC | 1.21394587 |
| 48 | PTK2 | 1.20361510 |
| 49 | MAPKAPK3 | 1.18973637 |
| 50 | BMPR2 | 1.18948804 |
| 51 | EPHA4 | 1.17594151 |
| 52 | STK38L | 1.12806247 |
| 53 | DAPK1 | 1.08510163 |
| 54 | CDK7 | 1.08382938 |
| 55 | MARK2 | 1.08159852 |
| 56 | MST4 | 1.07026060 |
| 57 | PBK | 1.06550882 |
| 58 | EPHB2 | 1.05591671 |
| 59 | PNCK | 1.04878160 |
| 60 | PINK1 | 1.03823606 |
| 61 | BCR | 1.02564299 |
| 62 | NME1 | 0.94530525 |
| 63 | PTK6 | 0.94397529 |
| 64 | RIPK1 | 0.91332193 |
| 65 | MAP3K14 | 0.90883346 |
| 66 | ERBB4 | 0.90654110 |
| 67 | CAMK4 | 0.88842628 |
| 68 | FGFR3 | 0.86168186 |
| 69 | NTRK3 | 0.85859241 |
| 70 | PRKCE | 0.85521424 |
| 71 | ERBB3 | 0.83735067 |
| 72 | PDGFRA | 0.82997073 |
| 73 | ERBB2 | 0.82435407 |
| 74 | TGFBR1 | 0.81087993 |
| 75 | LRRK2 | 0.80763978 |
| 76 | KDR | 0.78406506 |
| 77 | MAP3K7 | 0.78220100 |
| 78 | MUSK | 0.77204675 |
| 79 | FGFR2 | 0.76850364 |
| 80 | TAOK3 | 0.76473485 |
| 81 | STK38 | 0.75808000 |
| 82 | ADRBK1 | 0.75239614 |
| 83 | ITK | 0.73909968 |
| 84 | EPHA3 | 0.73884033 |
| 85 | TRPM7 | 0.73647422 |
| 86 | CAMK2A | 0.73112352 |
| 87 | DDR2 | 0.73017760 |
| 88 | MAP2K1 | 0.72894569 |
| 89 | WEE1 | 0.72661439 |
| 90 | PKN1 | 0.72006488 |
| 91 | BMX | 0.71205109 |
| 92 | GSK3A | 0.71068786 |
| 93 | MARK3 | 0.68033537 |
| 94 | ICK | 0.68023511 |
| 95 | MINK1 | 0.67420203 |
| 96 | PIK3CG | 0.66712625 |
| 97 | MTOR | 0.65389746 |
| 98 | ILK | 0.65354716 |
| 99 | PDK2 | 0.64892831 |
| 100 | FER | 0.64848211 |
| 101 | CHEK2 | 0.64025045 |
| 102 | MAP2K2 | 0.64004721 |
| 103 | PDGFRB | 0.63297494 |
| 104 | MAPK13 | 0.62640493 |
| 105 | MAPK12 | 0.62072480 |
| 106 | LATS1 | 0.62040965 |
| 107 | MAPKAPK5 | 0.61589588 |
| 108 | CAMK2D | 0.60884434 |
| 109 | TNIK | 0.60771635 |
| 110 | LIMK1 | 0.60039239 |
| 111 | FGFR4 | 0.59932084 |
| 112 | TXK | 0.57893810 |
| 113 | PRKCG | 0.54472689 |
| 114 | MAP3K10 | 0.54132026 |
| 115 | SIK3 | 0.51117184 |
| 116 | DAPK3 | 0.46549432 |
| 117 | CDK8 | 0.46509980 |
| 118 | PRKCI | 0.46309988 |
| 119 | TESK2 | 0.45950587 |
| 120 | CAMK2B | 0.45456930 |
| 121 | TLK1 | 0.45361719 |
| 122 | CHUK | 0.45343101 |
| 123 | PAK1 | 0.44005659 |
| 124 | HIPK2 | 0.43857630 |
| 125 | PLK4 | 0.42925591 |
| 126 | ROCK1 | 0.42892675 |
| 127 | CSK | 0.42192532 |
| 128 | CAMK2G | 0.42156461 |
| 129 | AKT2 | 0.41618200 |
| 130 | NEK9 | 0.40487617 |
| 131 | MAP2K7 | 0.40427199 |
| 132 | PDK3 | 0.40100275 |
| 133 | PDK4 | 0.40100275 |
| 134 | INSR | 0.39916934 |
| 135 | TTN | 0.39430919 |
| 136 | CSNK1A1L | 0.39302210 |
| 137 | MAP3K3 | 0.38844012 |
| 138 | IKBKB | 0.38369714 |
| 139 | ZAP70 | 0.37971910 |
| 140 | PRKG1 | 0.37234567 |
| 141 | IGF1R | 0.37046878 |
| 142 | PDK1 | 0.36241648 |
| 143 | BTK | 0.36027952 |
| 144 | PRKCD | 0.35466737 |
| 145 | PAK2 | 0.35351983 |
| 146 | PLK1 | 0.35216723 |
| 147 | PTK2B | 0.35099867 |
| 148 | EIF2AK2 | 0.34210203 |
| 149 | FGR | 0.33899685 |
| 150 | RPS6KB2 | 0.32892266 |
| 151 | PRKCA | 0.32832233 |
| 152 | ROCK2 | 0.32340196 |
| 153 | SYK | 0.31819143 |
| 154 | PRKAA2 | 0.31095477 |
| 155 | MAPKAPK2 | 0.30801953 |
| 156 | PRKD1 | 0.30765799 |
| 157 | MAP3K4 | 0.30740110 |
| 158 | PAK3 | 0.29559989 |
| 159 | CHEK1 | 0.29412077 |
| 160 | AKT3 | 0.28319570 |
| 161 | BCKDK | 0.28292052 |
| 162 | PRKACB | 0.26837992 |
| 163 | SRC | 0.26119410 |
| 164 | CDC42BPA | 0.26107624 |
| 165 | DYRK1A | 0.25592612 |
| 166 | IRAK1 | 0.24696634 |
| 167 | CSNK1E | 0.20128729 |
| 168 | STK3 | 0.19584000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.49280401 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.41373474 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.13274536 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.08798770 |
| 5 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.79985802 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76047790 |
| 7 | Platelet activation_Homo sapiens_hsa04611 | 2.61540228 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.48281987 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.30654167 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30503217 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29794721 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.03798884 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.01011359 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.00205030 |
| 15 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.97933853 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.97264085 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94997318 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.91193018 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.82185213 |
| 20 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.81888099 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.80434307 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.80270184 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.78820974 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78309756 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.76783917 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.69726873 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.69700137 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.67875082 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.62024564 |
| 30 | Tight junction_Homo sapiens_hsa04530 | 1.61925597 |
| 31 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.61506156 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60762752 |
| 33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.59749798 |
| 34 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.56446961 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.49590955 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48283551 |
| 37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.46840642 |
| 38 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.43364670 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34603039 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.33659130 |
| 41 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.32003939 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31046907 |
| 43 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.28502374 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27909767 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.26940230 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25681239 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 1.25570137 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.25389838 |
| 49 | Insulin secretion_Homo sapiens_hsa04911 | 1.24107205 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.23843847 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23321828 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.20677805 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17560947 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 1.17365439 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15974550 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11051097 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09574676 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.09517361 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.09461734 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09081335 |
| 61 | Long-term depression_Homo sapiens_hsa04730 | 1.08008912 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07397486 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07339023 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06827916 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06671305 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05107467 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02851121 |
| 68 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.02431262 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 1.01930176 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00195475 |
| 71 | Pathways in cancer_Homo sapiens_hsa05200 | 0.99650509 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99330936 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98888104 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95921178 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.91268778 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91265286 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.90466177 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88424434 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86088577 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.85795815 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85093401 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84858411 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81620132 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81212732 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80572802 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80567125 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.79184260 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78858731 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78674461 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78138851 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.77095780 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.76767579 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75952429 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75353060 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74348463 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72478816 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71899628 |
| 98 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71402397 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.70835784 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70816744 |
| 101 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70543414 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.70347090 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70123149 |
| 104 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69363569 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.69314879 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68561113 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68298420 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67464224 |
| 109 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67341292 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67188458 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66338559 |
| 112 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66091655 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65932853 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.65644605 |
| 115 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64504829 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64156181 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64146662 |
| 118 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63846017 |
| 119 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62898015 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62490125 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60322806 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.58630947 |
| 123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58621270 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53635868 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53380483 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52245713 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51455615 |
| 128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51204415 |
| 129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51155736 |
| 130 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50610894 |
| 131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50505489 |
| 132 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49741422 |
| 133 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44459231 |
| 134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44233232 |
| 135 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44027881 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43638025 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42210023 |
| 138 | Purine metabolism_Homo sapiens_hsa00230 | 0.41800617 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41221219 |
| 140 | Melanoma_Homo sapiens_hsa05218 | 0.40996432 |
| 141 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39825849 |
| 142 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39743747 |
| 143 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39611978 |
| 144 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39575018 |
| 145 | Homologous recombination_Homo sapiens_hsa03440 | 0.37832200 |
| 146 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37734580 |
| 147 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36748469 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.36288371 |
| 149 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34937651 |
| 150 | Lysine degradation_Homo sapiens_hsa00310 | 0.34883801 |
| 151 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34631132 |
| 152 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34259766 |
| 153 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34179403 |
| 154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34023975 |
| 155 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33403149 |
| 156 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32431587 |
| 157 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32271980 |

